Novonesis acquires remaining shares in MicroBioGen
In Denmark, Novonesis has signed an agreement with the intent to acquire MicroBioGen, an Australian biotechnology company with leading scientific expertise in yeast strains for industrial applications, particularly in bioethanol. The acquisition builds on Novonesis’ 2013 investment in MicroBioGen and its current 23% stake, further strengthening a decade-long collaboration in advanced yeast solutions for bioethanol production.
As a pure-play biology company, Novonesis combines deep scientific expertise in microbiology and industrial fermentation with approximately 10% of annual sales investment in innovation. The acquisition of MicroBioGen builds on this foundation, strengthening core expertise in biological solutions.
As part of the agreement, Novonesis will continue to support MicroBioGen’s existing partners and ensure continuity in its collaborations.
The terms of the transaction will not be disclosed, and completion of the transaction is subject to customary regulatory approvals, including by the ACCC (Australia’s national competition, consumer, fair trading and product safety regulator).
Category: Fuels
